FORT LAUDERDALE, Fla., April 3, 2017 /PRNewswire/ -- Fort Lauderdale-based private equity
The announcement comes on the heels of the firm's March 2017 commitment to invest $50MM to South Florida companies through the form of direct equity investments while leveraging its robust lending platform to increase its return on equity. IBS, N.A. senior executive Jason Jackson is expected to lead his firm to invest in at least 10 more South Florida-based companies prior to 2017 year-end. "I am excited to be partnered with IBS as both a financial services provider and equity partner. We look forward to increasing our supply of quality implants to the orthopedic community at a tremendous value as a result of the support of our suppliers and our new partner IBS," said Progressive Managing Director, T Bradley Harris.
Hip and knee replacements are the most common inpatient surgery for Medicare patients, with more than $7 billion spent on 360,000 procedures in 2014 alone. With the average total cost of care and recovery ranging between $18,000 and $35,000 per patient, Progressive's high-quality, low-cost alternative has garnered the attention of hospitals and distributors nationwide. "Our partnership with Brad and his team delivers Progressive a distinct advantage in accessing capital markets to ensure the appropriate inventory to demand ratios," IBS, N.A. Chairman and Chief Investment Officer Jason Jackson told reporters.
About IBS Investment Bank
IBS Investment Bank (IBS, NAŪ) is a privately held institutional banking firm dedicated to providing investment management and advisory, corporate finance, real estate finance, acquisition and management to its institutional clients. For more information visit www.ibsinvestmentbank.com or www.IBSREICO.com
About Progressive Orthopaedic Company
Progressive Orthopaedic is a full-line orthopedic implant distributor of low-cost orthopedic implants. The company is based on the usage of "stable orthopedic technologies". For more information, visit http://progressiveorthopaedics.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ibs-investment-bank-acquires-interest-in-the-progressive-orthopaedic-company-llc-300433899.html
SOURCE IBS Investment Bank
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All